Innovative MedTech Company Developing FDA-Approved Pain Management Device with Remote Monitoring

This listing presents an opportunity to invest in a groundbreaking MedTech company specializing in pain management and remote therapeutic monitoring. The company has developed a patent-protected, non-invasive medical device that addresses joint inflammation and promotes tissue regeneration through a unique combination of electrical and thermal stimulation. This Class I device, FDA-approved for pain management, offers non-opioid, long-term relief for chronic joint and spine pain, enhancing mobility and cartilage rejuvenation. Its smart cloud-supported technology enables remote monitoring, tracking patient adherence and device performance. Having successfully transitioned from pre-revenue to initial sales, the company is poised for significant growth with a pipeline of next-generation products. Projections indicate $16.6 million in revenues and $4.9 million in Adjusted EBITDA by 2027, targeting vast markets including integrated clinical practices, chiropractic, and physical therapy settings. The company is seeking a strategic or financial partner to facilitate further expansion, with founders open to a buyout to support future growth.